neuropharmacology
Sleep-Deprived Memories Restored by Common Medications
Health
Summary: Researchers have found that sleep deprivation can hide, rather than erase, memories in mice, and that these memories can be restored ...
Ozempic Boost Fullness Pre-Meal via Hypothalamus
Health
Summary: A new study shows GLP-1 receptor agonists increase pre-meal fullness by activating neurons in the dorsomedial hypothalamus. This mechanism helps prevent ...
Ozempic May Reduce Alzheimer’s Risk
Health
Summary: GLP-1 agonists like Ozempic reduce the risk of dementia in type 2 diabetes patients. The research followed over 88,000 individuals for ...
Synthetic Peptide Reverses Alzheimer’s Symptoms
Health
Summary: Researchers reversed Alzheimer’s symptoms in mice using a synthetic peptide, PHDP5, that targets brain function. The study shows that PHDP5 can ...
Cancer Drug May Halt Parkinson’s Spread
Health
Summary: Researchers discovered a novel therapeutic target for Parkinson’s disease, the Aplp1 protein, which facilitates the spread of harmful alpha-synuclein proteins in ...
AI-Powered Pills Track Gut Health in Real Time
Health
Summary: Scientists have created an AI-powered system to track ingestible devices that monitor disease markers in the gut. This non-invasive technology could ...
SSRIs Reveal New Potential Beyond Depression Treatment
Health
Summary: A new study uncovers a key biological process targeted by SSRIs, suggesting new clinical applications. The study found that SSRIs affect ...
Light-Activated Drug Induces Sleep by Targeting Brain Receptors
Health
Summary: Researchers developed a light-sensitive drug that enhances adenosine activity in the brain, inducing sleep in mice without genetic modification. This innovation ...
Ketamine’s Effect on Brain Activity Revealed
Health
Summary: A new computational model reveals how ketamine, a widely used anesthetic and antidepressant, affects brain activity. By simulating the drug’s interaction ...
GLP-1 and NMDA Targeted Weight-Loss Drug Shows Promise
Health
Summary: Researchers have developed a novel weight-loss drug that combines GLP-1 with molecules targeting NMDA receptors in the brain. This “Trojan Horse” ...
